Fastnet Equity’s strategy is to acquire companies or businesses in the healthcare sector, particularly those in the biopharma sector.

It is quoted on the AIM market of the London Stock Exchange and the Enterprise Securities Market (ESM) of the Irish Stock Exchange.

Share Price

Delivered by Investis (opens in a new window)